Navigation Links
NJIT receives second part of $1M gift to chemical engineering department
Date:7/7/2011

NJIT announced today the fulfillment of the late Otto H. York's $1M pledge to NJIT. Daughter of the visionary York, Myrth York of Providence, RI, presented NJIT with a check for $490,000 to complete the commitment to the Otto H. York Department of Chemical, Biological and Pharmaceutical Engineering. In 2002, the department was named in honor Otto H. York, chemical engineer, entrepreneur, philanthropist, and long-time benefactor of the university. York had pledged $1M to the department to establish an endowment supporting scholarships to attract outstanding students and to support faculty research.

"Over the years, NJIT has had many reasons to be grateful for the deep personal concern that Otto York showed for our university, and for his generous financial support," said NJIT President Robert A. Altenkirch. "But his concern and support are not just part of our past; they are very much invaluable components of our future. Otto York's legacy of engagement with the department of chemical, biological and pharmaceutical engineering that bears his name will enable NJIT to foster the talents of exceptional young women and men, and to maintain our leadership in disciplines vital to the prosperity of New Jersey and the nation."

The gift empowers Chairman Norman Loney, PhD, to actuate his five-year plan.

Following the Engineer of 2020 vision of the National Academy of Engineering (NEA), http://www.nae.edu/programs/education/activities10374/engineerof2020.aspx Loney's strategy connects diversity and industry. As his first initiative, Loney will bring on board a female university lecturer with professional pharmaceutical industry research experience who will help to pursue opportunities for NSF-funded student experiential education. The new faculty member will continue to connect with industry to build a long-range plan including increased hands-on exp
'/>"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Geneticist receives Excellence in Science Award from coalition of biomedical researchers
2. University of Texas at Austin professor receives Donald L. Katz Award
3. CSHL professor Rob Martienssen receives prestigious appointment as HHMI-GBMF investigator
4. Wildlife Conservation Society receives $150,000 grant from Newmans Own Foundation to save gorillas
5. Rensselaer scholar receives NSF Research Fellowship
6. Dr. Knut Stamnes at Stevens receives NASA grant for environmental monitoring
7. NTU receives $250,000 gift to promote groundbreaking research in sustainability
8. JGIs Susannah Tringe receives prestigious $2.5M DOE Early Career Research Award
9. Harvards engineering school receives $100,000 Grand Challenges Explorations grant
10. Yuemeng Dai, M.D., Ph.D., ear, nose and throat specialist, receives Bill Potsic Basic Science Award
11. Stephen Maturo, M.D., ear, nose and throat specialist, receives Charles Ferguson Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... from the University of Tbingen, Arizona State University, the ... Public Health Institute (Swiss TPH) isolated Mycobacterium pinnipedii ... least 1000 years old. The pathogen is a relative ... occasionally causes disease in humans today. These researchers assume ... Peruvian coast. "The link to sea lions was unexpected" ...
(Date:8/20/2014)... August 19, 2014 -- Bay Area Lyme Foundation, which ... simple to cure, applauds new research published in an ... Ticks and Tick-borne Diseases . The findings show ... are active throughout the year, making the threat of ... at California Department of Public Health (CDPH) Vector-borne Disease ...
(Date:8/20/2014)... -- When are athletes who have suffered concussions ready ... study has found that high school athletes who head ... days experience a significant regression in their abilities to ... regression, as seen in changes in their balance and/or ... athletes. Ten of the 12 had returned to activity ...
Breaking Biology News(10 mins):Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3Recovery reversal seen in Oregon study of returning concussed athletes 2Recovery reversal seen in Oregon study of returning concussed athletes 3
... searches blood for the tiniest remnants of broken down ... up cancer activators called proteases. The results improve researchers, ... to where to look for possible indicators of early ... , the research shows previously unknown contributing factors to ...
... The cells and tissues in our bodies grow, develop ... the various microbial pathogens that invade our bodies and ... milieu. Yet the methods of culturing and studying human ... on flat impermeable surfaces. While such 2-D culturing and ...
... with a peer facing the same self-management challenges helped ... sugar levels better than those who used traditional nurse ... University of Michigan Health System. The findings, published ... showed the peer partner program resulted in lower ...
Cached Biology News:New clues to how cancer-related proteins plasmin, thrombin lose inhibition 2New clues to how cancer-related proteins plasmin, thrombin lose inhibition 3New clues to how cancer-related proteins plasmin, thrombin lose inhibition 4The world is not flat: Exploring cells and tissues in three dimensions 2The world is not flat: Exploring cells and tissues in three dimensions 3The world is not flat: Exploring cells and tissues in three dimensions 4Diabetic adults' conditions improved after phone calls with fellow patients 2Diabetic adults' conditions improved after phone calls with fellow patients 3
(Date:8/20/2014)... patented university inventions licensed to biotechnology firms has ... To open these roadblocks, the researchers suggest that ... discovery stage could lead to faster commercialization down ... from discoveries made in university laboratories and licensed ... clinical trials, which have a high failure rate. ...
(Date:8/20/2014)... August 20, 2014 High performance ... apply the most complete climate and Earth system ... climate change issues. , Eight national laboratories, including ... the National Center for Atmospheric Research, four academic ... effort. Other participating national laboratories include Argonne, Brookhaven, ...
(Date:8/20/2014)... 20, 2014 Not long ago, it ... should be performed late in the development cycle – ... current regulatory trends suggest that, like many things GxP, ... In recent years, multiple drug sponsors have been required ... specific questions during phase I/II. It’s not only clinical ...
(Date:8/20/2014)... GraphDB™ 6.0 from ... the enterprise replication cluster, faster loading speeds, higher ... Elasticsearch. This release happens to coincide with a ... GraphDB™ was formerly known as OWLIM. ... enterprise resilient RDF triplestore will also benefit from ...
Breaking Biology Technology:Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 3Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 4
... Jan. 2 Nektar,Therapeutics, (Nasdaq: NKTR ) President ... at the upcoming JPMorgan 26th Annual Healthcare,Conference at the ... January 8, 2008, at 4:30 p.m. Pacific Time., ... and slideshow,webcast through a link posted on the Investor ...
... Cephalon, Inc. (Nasdaq:,CEPH) today announced that it has ... Food and Drug Administration (FDA) requesting approval of,TREANDA(R) ... patients,with indolent B-cell non-Hodgkin,s lymphoma (NHL) who have ... rituximab-containing,regimen. According to the National Cancer Institute, an ...
... MYL ) today,announced that Mylan Pharmaceuticals Inc. ... Drug Administration (FDA) for its Abbreviated New Drug,Application ... Balsalazide Disodium Capsules are the generic version of ... approximately,$130.9 million for the 12 months ending Sept. ...
Cached Biology Technology:Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 2Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 3Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma 4